GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
22 hedge funds and large institutions have $8.79M invested in Amplify Treatments, Testing and Advancements ETF in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
-3
Holders Change %
-12%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
10
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$1.79M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$488K |
| 3 |
LPL Financial
San Diego,
California
|
+$423K |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$237K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$123K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GWM
26
Geneos Wealth Management
Englewood,
Colorado
| – | -$17K | -500 | Closed |
|
27
Bank of America
Charlotte,
North Carolina
| – | -$6K | -200 | Closed |
|